George Triadafilopoulos

Summary

Affiliation: Stanford University
Country: USA

Publications

  1. ncbi request reprint Bowel dysfunction in postmenopausal women
    G Triadafilopoulos
    Gastroenterology Section, Palo Alto VA Health Care System 111 GI, CA 94304, USA
    Women Health 27:55-66. 1998
  2. ncbi request reprint Temperature-controlled radiofrequency energy delivery for gastroesophageal reflux disease: the Stretta procedure
    G Triadafilopoulos
    Section of Gastroenterology, VA Palo Alto Health Care System, California 94304, USA
    J Laparoendosc Adv Surg Tech A 11:333-9. 2001
  3. ncbi request reprint Endoscopic therapies for gastroesophageal reflux disease
    George Triadafilopoulos
    Gastroenterology Section, Palo Alto Veterans Affairs Health Care System, 111 G1, 3801 Miranda Avenue, Palo Alto, CA 94304, USA
    Curr Gastroenterol Rep 4:200-4. 2002
  4. ncbi request reprint Belching: dyspepsia or gastroesophageal reflux disease?
    Mona Lin
    Gastroenterology Section, Veterans Affairs Medical Center Palo Alto, and Division of Gastroenterology and Hepatology, Stanford University, Stanford, California 94304, USA
    Am J Gastroenterol 98:2139-45. 2003
  5. doi request reprint Injection therapies for variceal bleeding disorders of the GI tract
    Walter G Park
    Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, California 94305, USA
    Gastrointest Endosc 67:313-23. 2008
  6. ncbi request reprint GERD: the potential for endoscopic intervention
    George Triadafilopoulos
    Medical Service, Palo Alto Veterans Affairs Health Care System, Palo Alto, Calif, USA
    Dig Dis 22:181-8. 2004
  7. pmc Detection of endogenous biomolecules in Barrett's esophagus by Fourier transform infrared spectroscopy
    Thomas D Wang
    Division of Gastroenterology, Stanford University School of Medicine, Palo Alto Veterans Affairs Health Care System, Palo Alto, CA 94304, USA
    Proc Natl Acad Sci U S A 104:15864-9. 2007
  8. ncbi request reprint Cost-effectiveness model of endoscopic screening and surveillance in patients with gastroesophageal reflux disease
    Lauren B Gerson
    Division of Gastroenterology, Stanford University School of Medicine, Stanford, California 94305 5202, USA
    Clin Gastroenterol Hepatol 2:868-79. 2004
  9. ncbi request reprint Photodynamic therapy for the treatment of patients with Barrett's high-grade dysplasia and mucosal adenocarcinoma
    George Triadafilopoulos
    Division of Gastroenterology and Hepatology, Stanford University, CA 94305 5187, USA
    Nat Clin Pract Gastroenterol Hepatol 2:136-7. 2005
  10. pmc Gene expression changes associated with Barrett's esophagus and Barrett's-associated adenocarcinoma cell lines after acid or bile salt exposure
    Ying Hao
    Department of Medicine, Stanford University, Stanford, CA, USA
    BMC Gastroenterol 7:24. 2007

Collaborators

Detail Information

Publications53

  1. ncbi request reprint Bowel dysfunction in postmenopausal women
    G Triadafilopoulos
    Gastroenterology Section, Palo Alto VA Health Care System 111 GI, CA 94304, USA
    Women Health 27:55-66. 1998
    ..In this study, we investigated the nature and prevalence of gastrointestinal and irritable bowel syndrome (IBS)-type complaints in women going through their climacteric and postmenopausal periods...
  2. ncbi request reprint Temperature-controlled radiofrequency energy delivery for gastroesophageal reflux disease: the Stretta procedure
    G Triadafilopoulos
    Section of Gastroenterology, VA Palo Alto Health Care System, California 94304, USA
    J Laparoendosc Adv Surg Tech A 11:333-9. 2001
    ..More recently, temperature-controlled RF energy delivery has been applied for the treatment of gastroesophageal reflux disease (GERD)...
  3. ncbi request reprint Endoscopic therapies for gastroesophageal reflux disease
    George Triadafilopoulos
    Gastroenterology Section, Palo Alto Veterans Affairs Health Care System, 111 G1, 3801 Miranda Avenue, Palo Alto, CA 94304, USA
    Curr Gastroenterol Rep 4:200-4. 2002
    ..Future trends in endoscopic therapy are discussed...
  4. ncbi request reprint Belching: dyspepsia or gastroesophageal reflux disease?
    Mona Lin
    Gastroenterology Section, Veterans Affairs Medical Center Palo Alto, and Division of Gastroenterology and Hepatology, Stanford University, Stanford, California 94304, USA
    Am J Gastroenterol 98:2139-45. 2003
    ..In this retrospective study we evaluated the prevalence of belching in dyspepsia and GERD and the relation of belching to acid reflux events documented by pH monitoring...
  5. doi request reprint Injection therapies for variceal bleeding disorders of the GI tract
    Walter G Park
    Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, California 94305, USA
    Gastrointest Endosc 67:313-23. 2008
  6. ncbi request reprint GERD: the potential for endoscopic intervention
    George Triadafilopoulos
    Medical Service, Palo Alto Veterans Affairs Health Care System, Palo Alto, Calif, USA
    Dig Dis 22:181-8. 2004
    ....
  7. pmc Detection of endogenous biomolecules in Barrett's esophagus by Fourier transform infrared spectroscopy
    Thomas D Wang
    Division of Gastroenterology, Stanford University School of Medicine, Palo Alto Veterans Affairs Health Care System, Palo Alto, CA 94304, USA
    Proc Natl Acad Sci U S A 104:15864-9. 2007
    ....
  8. ncbi request reprint Cost-effectiveness model of endoscopic screening and surveillance in patients with gastroesophageal reflux disease
    Lauren B Gerson
    Division of Gastroenterology, Stanford University School of Medicine, Stanford, California 94305 5202, USA
    Clin Gastroenterol Hepatol 2:868-79. 2004
    ..The cost-effectiveness of screening strategies that incorporate these nonsurgical treatment modalities has not been determined...
  9. ncbi request reprint Photodynamic therapy for the treatment of patients with Barrett's high-grade dysplasia and mucosal adenocarcinoma
    George Triadafilopoulos
    Division of Gastroenterology and Hepatology, Stanford University, CA 94305 5187, USA
    Nat Clin Pract Gastroenterol Hepatol 2:136-7. 2005
  10. pmc Gene expression changes associated with Barrett's esophagus and Barrett's-associated adenocarcinoma cell lines after acid or bile salt exposure
    Ying Hao
    Department of Medicine, Stanford University, Stanford, CA, USA
    BMC Gastroenterol 7:24. 2007
    ..In this study, we determined whether similar exposure to acid or bile salts results in gene expression changes that provide insights into malignant transformation...
  11. ncbi request reprint Endotherapy and surgery for GERD
    George Triadafilopoulos
    Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, CA 94305 5187, USA
    J Clin Gastroenterol 41:S87-96. 2007
    ....
  12. ncbi request reprint Potential relationship between gastroesophageal reflux disease and atrial arrhythmias
    Lauren B Gerson
    Division of Gastroenterology, Stanford University School of Medicine, Stanford, CA 94605 5202, USA
    J Clin Gastroenterol 40:828-32. 2006
    ....
  13. ncbi request reprint Endoscopic therapy for Barrett's esophagus
    Ronald W Yeh
    Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Alway Building M 211, CA 94305, USA
    Gastrointest Endosc Clin N Am 15:377-97, vii. 2005
    ..In this article we review current published literature on endoscopic therapies for the management of Barrett's esophagus...
  14. ncbi request reprint Risk of serious upper gastrointestinal and cardiovascular thromboembolic complications with meloxicam
    Gurkirpal Singh
    Divisions of Immunology and Rheumatology, Department of Medicine, Stanford University School of Medicine, Stanford, California, USA
    Am J Med 117:100-6. 2004
    ..To assess the risk of serious gastrointestinal and thromboembolic complications with approved doses of meloxicam...
  15. ncbi request reprint Complete elimination of reflux symptoms does not guarantee normalization of intraesophageal and intragastric pH in patients with gastroesophageal reflux disease (GERD)
    David Milkes
    Department of Medicine Section of Gastroenterology, VA Palo Alto Health Care System, Palo Alto, California 94304, USA
    Am J Gastroenterol 99:991-6. 2004
    ..It is generally assumed that acid suppressive therapy improves or eliminates symptoms by normalizing intraesophageal pH...
  16. ncbi request reprint Acid- and bile-induced PGE(2) release and hyperproliferation in Barrett's esophagus are COX-2 and PKC-epsilon dependent
    Baljeet S Kaur
    Gastroenterology Section, Veterans Affairs Palo Alto Health Care System, CA 94304, USA
    Am J Physiol Gastrointest Liver Physiol 283:G327-34. 2002
    ..The acid- or bile salt-mediated hyperproliferation is related to PGE(2) release. Acid- and bile salt-induced induction of COX-2 and PKC may explain, at least in part, the tumor-promoting effects of acid and bile in BE...
  17. ncbi request reprint Prevalence of Barrett's esophagus in asymptomatic individuals
    Lauren B Gerson
    Section of Gastroenterology, VA Palo Alto Health Care System and Division of Gastroenterology, Stanford University School of Medicine, Stanford, California 94305 5202, USA
    Gastroenterology 123:461-7. 2002
    ..We prospectively screened for the presence of BE in asymptomatic subjects older than 50 years of age undergoing screening sigmoidoscopy for colorectal cancer...
  18. ncbi request reprint Screening for esophageal adenocarcinoma: an evidence-based approach
    Lauren B Gerson
    Department of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, California 94305 5202, USA
    Am J Med 113:499-505. 2002
    ..Several risk factors, including severe reflux symptoms, male sex, and obesity, may identify patients with gastroesophageal reflux disease who are at the greatest risk of the development of cancer...
  19. ncbi request reprint Clinical experience with the Stretta procedure
    George Triadafilopoulos
    Gastroenterology Section, VA Palo Alto Health Care System, 111 G1, 3801 Miranda Avenue, Palo Alto, CA 94304, USA
    Gastrointest Endosc Clin N Am 13:147-55. 2003
    ....
  20. doi request reprint Adverse effects of long-term proton pump inhibitor therapy
    Edward Sheen
    Department of Medicine and Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, CA 94305, USA
    Dig Dis Sci 56:931-50. 2011
    ..The benefits of proton pump inhibitor use outweigh its risks in most patients. Elderly, malnourished, immune-compromised, chronically ill, and osteoporotic patients theoretically could be at increased risk from long-term therapy...
  21. ncbi request reprint The management of anticoagulants in the periendoscopic period for patients with atrial fibrillation: a decision analysis
    Lauren B Gerson
    Division of Gastroenterology, Stanford University School of Medicine, California 94305 5202, USA
    Am J Med 116:451-9. 2004
    ..The management of patients who undergo endoscopy while being treated with warfarin is challenging. We used decision analysis to determine the preferred strategy to manage anticoagulants in the periendoscopic period...
  22. ncbi request reprint Celecoxib versus naproxen and diclofenac in osteoarthritis patients: SUCCESS-I Study
    Gurkirpal Singh
    Department of Medicine, Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, Calif 94301, USA
    Am J Med 119:255-66. 2006
    ..To evaluate the efficacy and upper gastrointestinal (UGI) safety of celecoxib, compared with nonspecific nonsteroidal anti-inflammatory drugs (NSAIDs), among patients with osteoarthritis...
  23. ncbi request reprint The Stretta procedure for the treatment of GERD: 6 and 12 month follow-up of the U.S. open label trial
    George Triadafilopoulos
    Gastroenterology and Otolaryngology Head and Neck Surgery Sections, VA Palo Alto Health Care System, Palo Alto, CA 94304, USA
    Gastrointest Endosc 55:149-56. 2002
    ..This multicenter prospective study investigated the longer-term (12 month) safety and efficacy of radiofrequency energy delivery for the treatment of GERD...
  24. doi request reprint A novel device for ablation of abnormal esophageal mucosa (with video)
    Shai Friedland
    Stanford University, Palo Alto, CA, USA
    Gastrointest Endosc 74:182-8. 2011
    ..Current ablation devices for Barrett's esophagus are effective but have significant limitations...
  25. ncbi request reprint Rofecoxib inhibits cyclooxygenase 2 expression and activity and reduces cell proliferation in Barrett's esophagus
    Baljeet S Kaur
    Gastroenterology Section, Veterans Affairs Palo Alto Health Care System, Palo Alto, California 94304, USA
    Gastroenterology 123:60-7. 2002
    ..COX-2 inhibition with the selective inhibitor rofecoxib may be important in chemoprevention of esophageal adenocarcinoma by decreasing cell proliferation...
  26. pmc The association between cholecystectomy and gastroesophageal reflux symptoms: a prospective controlled study
    Otto S Lin
    Gastroenterology Section, Digestive Disease Institute, Virginia Mason Medical Center, Seattle, WA 98101, USA
    Ann Surg 251:40-5. 2010
    ..A large controlled prospective observational study to compare pre- and postsurgery changes in reflux symptoms between cholecystectomy and hernia repair surgery patients...
  27. ncbi request reprint Use of health care resources and cost of care for adults with constipation
    Gurkirpal Singh
    Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Palo Alto, California, USA
    Clin Gastroenterol Hepatol 5:1053-8. 2007
    ..To evaluate the clinical and fiscal effects of constipation, we assessed health care resource use by patients with constipation enrolled in a large state Medicaid program...
  28. ncbi request reprint Patterns of use and public perception of over-the-counter pain relievers: focus on nonsteroidal antiinflammatory drugs
    C Mel Wilcox
    Department of Medicine, Division of Gastroenterology, University of Alabama at Birmingham, Alabama 35294 0007, USA
    J Rheumatol 32:2218-24. 2005
    ..To assess the frequency and indications for over-the-counter (OTC) nonsteroidal antiinflammatory drug (NSAID) use and to what degree the public is aware of their side effects...
  29. ncbi request reprint Stretta: an effective, minimally invasive treatment for gastroesophageal reflux disease
    George Triadafilopoulos
    Stanford University School of Medicine, Stanford, California, USA
    Am J Med 115:192S-200S. 2003
    ....
  30. pmc Time esophageal pH < 4 overestimates the prevalence of pathologic esophageal reflux in subjects with gastroesophageal reflux disease treated with proton pump inhibitors
    Lauren B Gerson
    Stanford University School of Medicine, Stanford, CA, USA
    BMC Gastroenterol 8:15. 2008
    ..A Stanford University study reported that in asymptomatic GERD patients who were being treated with a proton pump inhibitor (PPI), 50% had pathologic esophageal acid exposure...
  31. ncbi request reprint Features of gastroesophageal reflux disease in women
    Mona Lin
    Division of Gastroenterology, Stanford University School of Medicine, Stanford, California, USA
    Am J Gastroenterol 99:1442-7. 2004
    ..In this study, we evaluated the patterns of symptomatic GERD and the spectrum of disease activity in women and compared them to a cohort of disease- and age-matched men...
  32. ncbi request reprint Five-year colon surveillance after screening colonoscopy
    David A Lieberman
    Department of Veterans Affairs Medical Center, Portland, Oregon 97239, USA
    Gastroenterology 133:1077-85. 2007
    ..Outcomes of colon surveillance after colorectal cancer screening with colonoscopy are uncertain. We conducted a prospective study to measure incidence of advanced neoplasia in patients within 5.5 years of screening colonoscopy...
  33. ncbi request reprint Injection therapies for nonvariceal bleeding disorders of the GI tract
    Walter G Park
    Division of Gastroenterology and Hepatology, Stanford University, Stanford, California 94305, USA
    Gastrointest Endosc 66:343-54. 2007
  34. ncbi request reprint Cost-effectiveness of photodynamic therapy for high-grade dysplasia in Barrett's esophagus
    Rohini Vij
    Division of Gastroenterology and Hepatology, Center for Primary Care and Outcomes Research, Department of Medicine, Stanford University School of Medicine, California, USA
    Gastrointest Endosc 60:739-56. 2004
    ..Our aim was to identify the most effective and cost-effective strategy for managing high-grade dysplasia in Barrett's esophagus without associated endoscopically visible abnormalities...
  35. ncbi request reprint Patient-derived health state utilities for gastroesophageal reflux disease
    Lauren B Gerson
    Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, California, USA
    Am J Gastroenterol 100:524-33. 2005
    ..Gastroesophageal reflux disease is a chronic disease that adversely affects health-related quality of life. The purpose of this study was to derive health state utilities for patients with chronic heartburn symptoms...
  36. ncbi request reprint Endotherapy for GERD: angels and demons
    George Triadafilopoulos
    Gastrointest Endosc 61:668-70. 2005
  37. doi request reprint Circumferential ablation of Barrett's esophagus that contains high-grade dysplasia: a U.S. Multicenter Registry
    Robert A Ganz
    Minnesota Gastroenterology, Plymouth, Minnesota 55446, USA
    Gastrointest Endosc 68:35-40. 2008
    ..The management strategies for Barrett's esophagus (BE) that contains high-grade dysplasia (HGD) include intensive endoscopic surveillance, photodynamic therapy, thermal ablation, EMR, and esophagectomy...
  38. ncbi request reprint Submucosal injection: safety cushion at what cost?
    Ronald W Yeh
    Gastrointest Endosc 62:943-5. 2005
  39. ncbi request reprint Endoscopic antireflux therapy: the Stretta procedure
    Ronald W Yeh
    Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Alway Building M 211, 300 Pasteur Drive, Stanford, CA 94305, USA
    Thorac Surg Clin 15:395-403. 2005
    ....
  40. ncbi request reprint Colorectal neoplasia in veterans is associated with Barrett's esophagus but not with proton-pump inhibitor or aspirin/NSAID use
    Peter D Siersema
    Departments of Gastroenterology and Hepatology and Public Health, Erasmus MC University Medical Center Rotterdam, 3000 CA Rotterdam, The Netherlands
    Gastrointest Endosc 63:581-6. 2006
    ..It has been suggested that Barrett's esophagus (BE) is associated with an increased risk of developing colorectal neoplasia, but this has not been reported consistently...
  41. ncbi request reprint Bravura for Bravo pH monitoring
    George Triadafilopoulos
    Gastrointest Endosc 63:1051-4. 2006
  42. pmc Gene expression profiling reveals stromal genes expressed in common between Barrett's esophagus and adenocarcinoma
    Ying Hao
    Department of Medicine, Stanford University, Stanford, California 94305 5187, USA
    Gastroenterology 131:925-33. 2006
    ....
  43. ncbi request reprint Autofluorescence imaging: have we finally seen the light?
    Thomas D Wang
    Gastrointest Endosc 61:686-8. 2005
  44. ncbi request reprint Clinical, radiologic, and manometric characteristics of chronic intestinal dysmotility: the Stanford experience
    Lucilene Rosa-E-Silva
    Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, California 94305, USA
    Clin Gastroenterol Hepatol 4:866-73. 2006
    ..We determined the spectrum of motor abnormalities, underlying pathology, clinical course, and response to treatment of adults with CID at a tertiary referral center...
  45. ncbi request reprint Nonsteroidal anti-inflammatory drug use does not affect short-term endoscopic and histologic outcomes after Helicobacter pylori eradication in patients with rheumatoid arthritis
    Eiichi Tanaka
    Institute of Rheumatology, Tokyo Women s Medical University, Tokyo 162 0054, Japan
    Mod Rheumatol 17:228-34. 2007
    ..5 months, use of NSAIDs in Japanese patients with RA did not impair the healing process of gastric and duodenal ulcers nor did it affect the endoscopic and histological improvements associated with H. pylori eradication...
  46. ncbi request reprint Exercise and gastrointestinal function and disease: an evidence-based review of risks and benefits
    Luke Bi
    Division of Gastroenterology, Department of Medicine, College of Medicine, University of California at Irvine, Orange, CA, USA
    Clin Gastroenterol Hepatol 1:345-55. 2003
    ....
  47. doi request reprint Low proportion of Barrett's esophagus in Asian Americans
    Khoa D Lam
    Stanford University, Stanford, California, USA
    Am J Gastroenterol 103:1625-30. 2008
    ..To determine the proportion of Barrett's esophagus (BE) in Asians versus non-Asians and the predictors of BE in patients with upper gastrointestinal (GI) symptoms...
  48. ncbi request reprint Guide to the use of proton pump inhibitors in adult patients
    Vandana Boparai
    Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, California 94305 5187, USA
    Drugs 68:925-47. 2008
    ..Various clinical endpoints, such as symptom relief, mucosal healing, prevention of disease recurrence or complications, and cancer chemoprevention, are discussed and unmet needs are highlighted...
  49. ncbi request reprint A message from the Editor-in-Chief: GIE at the frontier of endoscopy
    George Triadafilopoulos
    Gastrointest Endosc 61:99-101. 2005
  50. pmc Neuro-regulation of lower esophageal sphincter function as treatment for gastroesophageal reflux disease
    Anupender Singh Sidhu
    World J Gastroenterol 14:985-90. 2008
    ..Alterations of the structure and function of the EGJ and the LES may predispose to gastroesophageal reflux disease (GERD)...
  51. ncbi request reprint Communicating with patients with inflammatory bowel disease
    Ali Husain
    Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA
    Inflamm Bowel Dis 10:444-50; discussion 451. 2004
    ..We hope that our review will form a framework by which different members of the medical team learn their roles in the complex management decisions affecting IBD patients...
  52. ncbi request reprint Injection therapies for nonbleeding disorders of the GI tract
    Ronald W Yeh
    Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, California, USA
    Gastrointest Endosc 64:399-411; quiz 389-92. 2006
  53. ncbi request reprint Interventional upper endoscopy: the adult perspective
    Tonya Kaltenbach
    Division of Gastroenterology and Hepatology, Stanford University School of Medicine, 300 Pasteur Drive, Alway Building M 211, Stanford, CA 94305, USA
    Curr Gastroenterol Rep 8:443-9. 2006
    ....